Birth Asphyxia Clinical Trial
— Intra-OOfficial title:
Birth Asphyxia in Uganda: Prevalence, Associated Factors and Effect of Intrapartum Oxygen Administration on Fetal and Early Neonatal Outcomes
Introduction Birth asphyxia is one of leading causes of neonatal mortality in Uganda. It is
associated with long term neuro-developmental complications among the babies that survive.
Preventive measures for birth asphyxia intrauterine are not clearly understood and thus the
need for this study.
The aim of the study is to assess the effect of intrapartum oxygen administration on fetal
and early neonatal outcomes.
Methods A double-blind randomized clinical trial which will be conducted in Gulu regional
referral and Kawempe National referral hospitals in Uganda. A total sample size of 1108 women
in labour will be enrolled with 554 participants per group. The intervention will include
administration of 10 L/min of 100% oxygen for 15 minutes to women in established labor who
have signs of fetal distress with fetal heart rate of less than 120 or above 160 beats per
minute. The control group will receive medical air (21% oxygen) using the same criteria.
Women and babies will be followed up until 7 days after birth to document the outcomes.
Statistical analysis to identify difference in outcomes between the control and intervention
groups will be performed.
Ethical considerations Ethical approval and permission was received from relevant research
and ethics committees. Informed consent will be sought from the participants. A data and
safety monitoring board will be set up to review periodically the progress of the clinical
trial study. Participants will be monitored for adverse events and severe adverse events;
reporting will be done according to the research and ethics committee guidelines.
Status | Recruiting |
Enrollment | 1108 |
Est. completion date | October 30, 2020 |
Est. primary completion date | August 30, 2020 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - Women in active first stage of labor who develop fetal distress will be included Exclusion Criteria: - Women in labor with critical conditions such as eclampsia, chronic heart disease, chronic lung disease and chronic renal failure - Women in preterm labor - Those taking Bleomycin and Amiodarone medications |
Country | Name | City | State |
---|---|---|---|
Uganda | Kawempe National Referral Hospital | Kampala |
Lead Sponsor | Collaborator |
---|---|
Makerere University | Swedish International Development Cooperation Agency (SIDA) |
Uganda,
Adanikin AI, Awoleke JO. Clinical suspicion, management and outcome of intrapartum foetal distress in a public hospital with limited advanced foetal surveillance. J Matern Fetal Neonatal Med. 2017 Feb;30(4):424-429. Epub 2016 Apr 25. — View Citation
Bullens LM, Moors S, van Runnard Heimel PJ, van der Hout-van der Jagt MB, Oei SG. Practice variation in the management of intrapartum fetal distress in The Netherlands and the Western world. Eur J Obstet Gynecol Reprod Biol. 2016 Oct;205:48-53. doi: 10.1016/j.ejogrb.2016.08.012. Epub 2016 Aug 16. — View Citation
Casey BM, McIntire DD, Leveno KJ. The continuing value of the Apgar score for the assessment of newborn infants. N Engl J Med. 2001 Feb 15;344(7):467-71. — View Citation
Dawood MA, Al-Arnous MA. The Effect of Maternal Oxygen Adminstration During The Second Stage of Normal Vaginal Delivery Or During Cesarean Section Under General Anaesthesia On Umblical Cord Blood Gases and Acid-Base State. Alexandria Journal of Pediatrics. 2002;16(2):233.
Fawole B, Hofmeyr GJ. Maternal oxygen administration for fetal distress. Cochrane Database Syst Rev. 2012 Dec 12;12:CD000136. doi: 10.1002/14651858.CD000136.pub2. Review. — View Citation
Garite TJ, Simpson KR. Intrauterine resuscitation during labor. Clin Obstet Gynecol. 2011 Mar;54(1):28-39. doi: 10.1097/GRF.0b013e31820a062b. — View Citation
Lawton J, Snowdon C, Morrow S, Norman JE, Denison FC, Hallowell N. Recruiting and consenting into a peripartum trial in an emergency setting: a qualitative study of the experiences and views of women and healthcare professionals. Trials. 2016 Apr 11;17:195. doi: 10.1186/s13063-016-1323-3. — View Citation
Morales P, Bustamante D, Espina-Marchant P, Neira-Peña T, Gutiérrez-Hernández MA, Allende-Castro C, Rojas-Mancilla E. Pathophysiology of perinatal asphyxia: can we predict and improve individual outcomes? EPMA J. 2011 Jun;2(2):211-30. doi: 10.1007/s13167-011-0100-3. Epub 2011 Jul 26. — View Citation
Pildner von Steinburg S, Boulesteix AL, Lederer C, Grunow S, Schiermeier S, Hatzmann W, Schneider KT, Daumer M. What is the "normal" fetal heart rate? PeerJ. 2013 Jun 4;1:e82. doi: 10.7717/peerj.82. Print 2013. — View Citation
Simpson KR. Intrauterine resuscitation during labor: review of current methods and supportive evidence. J Midwifery Womens Health. 2007 May-Jun;52(3):229-37. Review. — View Citation
Siriussawakul A, Triyasunant N, Nimmannit A, Ngerncham S, Hirunkanokpan P, Luang-Aram S, Pechpaisit N, Wangdee A, Ruangvutilert P. Effects of supplemental oxygen on maternal and neonatal oxygenation in elective cesarean section under spinal anesthesia: a randomized controlled trial. Biomed Res Int. 2014;2014:627028. doi: 10.1155/2014/627028. Epub 2014 Feb 20. — View Citation
Thorp JA, Trobough T, Evans R, Hedrick J, Yeast JD. The effect of maternal oxygen administration during the second stage of labor on umbilical cord blood gas values: a randomized controlled prospective trial. Am J Obstet Gynecol. 1995 Feb;172(2 Pt 1):465-74. — View Citation
Vernon G, Alfirevic Z, Weeks A. Issues of informed consent for intrapartum trials: a suggested consent pathway from the experience of the Release trial [ISRCTN13204258]. Trials. 2006 May 11;7:13. — View Citation
Weeke LC, Vilan A, Toet MC, van Haastert IC, de Vries LS, Groenendaal F. A Comparison of the Thompson Encephalopathy Score and Amplitude-Integrated Electroencephalography in Infants with Perinatal Asphyxia and Therapeutic Hypothermia. Neonatology. 2017;112(1):24-29. doi: 10.1159/000455819. Epub 2017 Feb 17. — View Citation
* Note: There are 14 references in all — Click here to view all references
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Normalization of the fetal heart rate | The fetal heart rate will be between 120 to 160 beats per minute | 30 minutes | |
Secondary | Birth Asphyxia | Five minute Apgar score of less than 7 at 5 minutes. Apgar Score refers to Appearance, pulse, grimace, activity and respiration. Each of these 5 elements are scored from 0-2 where by 0 is the worst score meaning absence of the parameter while 2 is the best score. A total of 0 means that the newborn has no signs of life, 1-6 refers to an infant with asphyxia while infants with scores of 7 to 10 are considered normal. | At 5 minutes after birth | |
Secondary | Hypoxic Ischemic encephalopathy | Hypoxic ischemic encephalopathy defined by Thompson Scores of 15 or more. This score is made of 9 signs assessed on a scale of 0-3. These are tone, level of consciousness, fits, posture, moro reflex, grasp reflex, suck, respiration and fontanel. Tone, level of consiciousness and posture are scored on a scale of 0-3 while the rest are scored on a scale of 0-2. A score of 0 for each individual item means normal while 2 or 3 refers to more severe problems. The lower the score, the better for a newborn.The maximum total score is 22 and scores of less than 10 are considered normal. However in this study, we shall consider scores of 15 or more as hypoxic ischemic encephalopathy. | 24 hours and 7 days after birth | |
Secondary | Neonatal Acidosis | Neonatal acidosis defined by cord artery lactate of more than 5.5mmol/l taken after delivery | Within 5 minutes of birth | |
Secondary | Status of newborn | Status of newborn indicating whether baby is alive or dead | 7 days after birth |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01913340 -
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO)
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT04169191 -
Sildenafil to Repair Brain Injury Secondary to Birth Asphyxia
|
Phase 1 | |
Completed |
NCT02858583 -
SI + CC Versus 3:1 C:V Ratio During Neonatal CPR
|
N/A | |
Recruiting |
NCT03682042 -
Comparative Outcomes Related to Delivery-room Cord Milking In Low-resourced Kountries Developmental Follow Up
|
N/A | |
Recruiting |
NCT03657394 -
Comparative Outcomes Related to Delivery-room Cord Milking In Low-resourced Kountries
|
N/A | |
Withdrawn |
NCT03681314 -
Umbilical Cord Milking in Neonates Who Are Depressed at Birth-Developmental Follow Up (MIDAB-FU)
|
N/A | |
Completed |
NCT02862925 -
Introducing Fetal Scalp Stimulation as an Adjunct to Intermittent Auscultation in Low-Resource Settings.
|
N/A | |
Completed |
NCT01751945 -
Improved Accessibility of EmONC Services for Maternal and Newborn Health: a Community Based Project
|
N/A | |
Terminated |
NCT03885492 -
The Baby-Saver Kit: Clinical Testing of a Device for Neonatal Resuscitation With Intact Cord in Uganda
|
||
Completed |
NCT01743742 -
First-day High Dose Vitamin C, E in Severe Birth Asphyxia
|
Phase 4 | |
Completed |
NCT05946681 -
Sildenafil Citrate to Improve Maternal and Neonatal Outcomes in Low-resource Settings
|
||
Recruiting |
NCT03577054 -
Development of a Mobile Application for HBB Prompt Study
|
N/A | |
Active, not recruiting |
NCT05854745 -
Comparison of Virtual Training to In-Person Training of Helping Babies Breathe in Ethiopia
|
N/A | |
Not yet recruiting |
NCT05707962 -
Neuroprotective Efficacy of Postnatal Magnesium Sulphate in Term Infants With Birth Asphyxia
|
N/A | |
Completed |
NCT01869582 -
Safer Births - Reducing Perinatal Mortality
|
N/A | |
Completed |
NCT01350765 -
Naushero Feroze Neonatal Survival Project
|
N/A | |
Completed |
NCT01865656 -
A Skills and Drills Intervention for Emergency Obstetrics and Neonatal Care at First Referral Units of North Karnataka
|
N/A | |
Active, not recruiting |
NCT04714502 -
Asphyxia Associated Metabolite Biomarker Investigation 2
|
||
Recruiting |
NCT05275725 -
Finding Solutions to Thrive After Birth Asphyxia in Africa
|
Phase 1 | |
Completed |
NCT04820504 -
Augmented Infant Resuscitator to Enhance Newborn Ventilation
|
N/A |